| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,859 |
13,601 |
$1.46M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,914 |
6,700 |
$1.14M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
23,435 |
8,565 |
$1.00M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,075 |
2,791 |
$531K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,680 |
8,590 |
$486K |
| G0378 |
Hospital observation service, per hour |
2,152 |
1,749 |
$324K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,157 |
2,840 |
$242K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,584 |
7,166 |
$159K |
| 97162 |
|
2,546 |
2,440 |
$138K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,383 |
1,314 |
$123K |
| 97161 |
|
2,152 |
2,048 |
$115K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,373 |
5,675 |
$89K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,895 |
1,689 |
$77K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,780 |
1,585 |
$72K |
| 80053 |
Comprehensive metabolic panel |
19,610 |
15,859 |
$69K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
897 |
795 |
$65K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,656 |
768 |
$64K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,739 |
1,606 |
$56K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,829 |
15,790 |
$49K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
864 |
793 |
$48K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
333 |
302 |
$46K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,016 |
1,712 |
$41K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,988 |
2,710 |
$40K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,674 |
1,205 |
$35K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,585 |
1,402 |
$33K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
494 |
459 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
6,180 |
5,370 |
$32K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,039 |
929 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,308 |
6,669 |
$31K |
| 97014 |
|
2,940 |
1,306 |
$29K |
| 76830 |
Ultrasound, transvaginal |
396 |
370 |
$29K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
570 |
501 |
$20K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
250 |
238 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
21,858 |
17,504 |
$19K |
| 97163 |
|
323 |
313 |
$19K |
| 83690 |
|
7,236 |
6,116 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,959 |
2,631 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,184 |
1,973 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
942 |
879 |
$17K |
| 84484 |
|
5,868 |
3,941 |
$17K |
| 97535 |
Self-care/home management training, each 15 minutes |
875 |
563 |
$15K |
| 96376 |
|
2,654 |
1,644 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
1,316 |
1,178 |
$15K |
| 84703 |
|
4,466 |
3,874 |
$13K |
| 97116 |
|
786 |
281 |
$13K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,978 |
5,055 |
$13K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
69 |
65 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
752 |
678 |
$12K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
752 |
678 |
$12K |
| 94060 |
|
295 |
282 |
$11K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
647 |
597 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
120 |
110 |
$11K |
| 83605 |
|
2,928 |
2,015 |
$10K |
| 93971 |
|
199 |
175 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,076 |
3,303 |
$9K |
| 83880 |
|
1,067 |
939 |
$8K |
| C1776 |
Joint device (implantable) |
27 |
25 |
$8K |
| 80061 |
Lipid panel |
1,984 |
1,802 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
432 |
407 |
$7K |
| 87040 |
|
2,299 |
1,076 |
$7K |
| 97165 |
|
206 |
187 |
$7K |
| 94726 |
|
228 |
219 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
484 |
389 |
$6K |
| 81001 |
|
5,254 |
4,534 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,241 |
2,044 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,404 |
4,610 |
$5K |
| 72100 |
|
293 |
261 |
$5K |
| 94729 |
|
212 |
204 |
$5K |
| 64447 |
|
173 |
156 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,863 |
1,936 |
$5K |
| 85027 |
|
3,268 |
2,685 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,629 |
1,436 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,532 |
4,773 |
$4K |
| 81025 |
|
2,000 |
1,809 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,321 |
1,766 |
$4K |
| J3490 |
Unclassified drugs |
2,150 |
1,741 |
$3K |
| 73030 |
|
266 |
223 |
$3K |
| 74018 |
|
232 |
209 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
42 |
39 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,089 |
4,091 |
$3K |
| 94760 |
|
3,539 |
2,246 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
478 |
392 |
$3K |
| 85379 |
|
800 |
712 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
25 |
25 |
$3K |
| 81003 |
|
3,680 |
3,276 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
471 |
428 |
$3K |
| 83735 |
|
1,657 |
1,201 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
207 |
188 |
$3K |
| 84702 |
|
422 |
361 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,205 |
957 |
$3K |
| 85730 |
|
1,589 |
1,387 |
$2K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
1,644 |
1,416 |
$2K |
| 73630 |
|
171 |
147 |
$2K |
| 82077 |
|
497 |
434 |
$2K |
| 84439 |
|
1,126 |
1,017 |
$2K |
| 0450 |
Emergency room services |
57 |
49 |
$2K |
| 85610 |
|
2,443 |
2,022 |
$2K |
| 73610 |
|
119 |
105 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,997 |
3,916 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,237 |
6,976 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
46 |
39 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
12 |
$2K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
14 |
13 |
$2K |
| 97012 |
|
205 |
111 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
120 |
110 |
$2K |
| 86780 |
|
271 |
246 |
$2K |
| 82962 |
|
3,277 |
1,482 |
$2K |
| 86140 |
|
897 |
777 |
$2K |
| 76801 |
|
28 |
24 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,006 |
2,675 |
$1K |
| 71250 |
|
16 |
13 |
$1K |
| 87077 |
|
550 |
423 |
$1K |
| 87641 |
|
117 |
110 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
59 |
51 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,447 |
2,549 |
$1K |
| 99152 |
|
305 |
254 |
$1K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
564 |
432 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
380 |
323 |
$1K |
| 76536 |
|
13 |
12 |
$1K |
| 87081 |
|
328 |
300 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,794 |
1,363 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
3,587 |
3,200 |
$965.17 |
| 86901 |
|
707 |
582 |
$735.52 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
40 |
26 |
$723.22 |
| 87186 |
|
247 |
206 |
$655.26 |
| 73562 |
|
31 |
26 |
$641.64 |
| 85652 |
|
766 |
662 |
$634.77 |
| 86900 |
|
154 |
121 |
$614.40 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
587 |
530 |
$611.24 |
| 82607 |
|
149 |
136 |
$583.22 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
853 |
701 |
$523.53 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15 |
15 |
$522.70 |
| 73130 |
|
33 |
25 |
$515.49 |
| 76775 |
|
19 |
17 |
$486.88 |
| 87640 |
|
101 |
94 |
$486.15 |
| 73110 |
|
30 |
27 |
$481.29 |
| 84145 |
|
74 |
52 |
$479.59 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
118 |
98 |
$463.73 |
| 86803 |
|
88 |
80 |
$453.94 |
| 80305 |
|
117 |
106 |
$441.56 |
| J2060 |
Injection, lorazepam, 2 mg |
828 |
630 |
$421.56 |
| 64415 |
|
14 |
12 |
$399.70 |
| 72040 |
|
27 |
25 |
$365.42 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
44 |
37 |
$288.86 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
161 |
95 |
$228.55 |
| 82728 |
|
42 |
38 |
$225.92 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,217 |
3,083 |
$199.83 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
298 |
163 |
$199.63 |
| 82570 |
|
184 |
147 |
$179.31 |
| J1630 |
Injection, haloperidol, up to 5 mg |
198 |
167 |
$171.29 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
28 |
12 |
$149.92 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
99 |
39 |
$147.29 |
| 83540 |
|
80 |
67 |
$143.93 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
99 |
39 |
$139.47 |
| 96367 |
|
25 |
13 |
$133.45 |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
127 |
115 |
$111.45 |
| 86850 |
|
62 |
54 |
$88.63 |
| 84100 |
|
82 |
63 |
$81.56 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
42 |
36 |
$78.49 |
| 87070 |
|
14 |
12 |
$59.18 |
| 87400 |
|
50 |
48 |
$48.71 |
| 83550 |
|
27 |
25 |
$47.80 |
| 82043 |
|
57 |
55 |
$47.40 |
| 84481 |
|
12 |
12 |
$42.85 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
56 |
39 |
$42.24 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
13 |
$37.50 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
71 |
51 |
$36.80 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
158 |
83 |
$34.04 |
| 82550 |
|
19 |
15 |
$26.44 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
52 |
46 |
$22.02 |
| 81002 |
|
46 |
38 |
$19.66 |
| 85007 |
|
15 |
14 |
$15.87 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
173 |
152 |
$5.91 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,225 |
1,090 |
$2.57 |
| A9270 |
Non-covered item or service |
15,523 |
1,902 |
$1.50 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
101 |
78 |
$0.60 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
12 |
12 |
$0.20 |
| A6222 |
Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
45 |
41 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
40 |
36 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
489 |
361 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
133 |
129 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
44 |
42 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
165 |
153 |
$0.00 |